• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CHRISTOPH MIETHKE GMBH & CO. KG SHUNTASST 25 W/ATT DISTAL & PROX TUBING; HYDROCEPHALUS MANAGEMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CHRISTOPH MIETHKE GMBH & CO. KG SHUNTASST 25 W/ATT DISTAL & PROX TUBING; HYDROCEPHALUS MANAGEMENT Back to Search Results
Model Number FV257T
Device Problem Infusion or Flow Problem (2964)
Patient Problem Patient Problem/Medical Problem (2688)
Event Date 12/16/2019
Event Type  Injury  
Manufacturer Narrative
Height: 183 cm.When additional information becomes available a follow up report will be submitted.
 
Event Description
It was reported the valve was blocked.The reporter indicated that a 5 year 27 day post operative valve was blocked and required explantation.Additional information was not provided.
 
Manufacturer Narrative
Investigation: visual inspection: no significant deformations or damage of the valves were detected during the visual inspection.Permeability test: a permeability test has shown that the valve is permeable.Adjustment test: for the shunt assistant the adjustment test is not applicable, because it is a valve with a fixed pressure.Braking force and brake function test: for the shunt assistant the test is not applicable, because it is a valve with a fixed pressure.Results: first, we performed a visual inspection of the valve.No significant deformations or damages of the valve are detected during the visual inspection.Further, we tested the permeability of the valve.The test has shown, that the valve is permeable.In order to verify whether the valve is compromised by the known risks of hydrocephalus therapy, e.G.By a build-up of natural substances (protein, blood or tissue particles) in the cerebrospinal fluid1, we have dismantled the valve.There were no visible deposits observed inside the shunt assistant.Based on our investigation results, we cannot confirm the suspicion of a blockage.We can exclude a defect at the time of release.The valve met all specifications of the final inspection when released from christoph miethke gmbh & co.Kg.Further actions: no further actions are required in our point of view.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SHUNTASST 25 W/ATT DISTAL & PROX TUBING
Type of Device
HYDROCEPHALUS MANAGEMENT
Manufacturer (Section D)
CHRISTOPH MIETHKE GMBH & CO. KG
2 ulanenweg
potsdam d, 14469
GM  14469
MDR Report Key9591886
MDR Text Key175093073
Report Number3004721439-2020-00018
Device Sequence Number1
Product Code JXG
Combination Product (y/n)N
PMA/PMN Number
K011030
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup
Report Date 01/21/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/15/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date12/13/2017
Device Model NumberFV257T
Device Catalogue NumberFV257T
Device Lot Number20018869
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer12/19/2019
Date Manufacturer Received01/10/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age80 MO
Patient Weight80
-
-